Priapism, an emerging complication in β-thalassemia intermedia patients

dc.contributor.authorMallat, Naji S.
dc.contributor.authorWehbe, David
dc.contributor.authorHaddad, Anthony G.
dc.contributor.authorCappellini, Maria Teresa
dc.contributor.authorMarcon, Alessia
dc.contributor.authorKoussa, Suzanne C.
dc.contributor.authorAbboud, Miguel Raul
dc.contributor.authorRadwan, Amr H.
dc.contributor.authorTaher, Ali T.
dc.contributor.departmentInternal Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:43:01Z
dc.date.available2025-01-24T11:43:01Z
dc.date.issued2014
dc.description.abstractThe increase in survival rate of β-thalassemia (β-thal) patients allowed for the appearance and manifestation of several complications in almost every organ system. Priapism in β-thal patients is rarely reported in the literature. We herein report and investigate the occurrence of two cases of priapism in two young patients with β-thal intermedia (β-TI). The potential mechanisms are due to either a cellular mechanism involving a thrombus obstructing the efferent venules of the corpora cavernosa leading to priapism, or a recently elucidated functional mechanism that causes alteration of nitric oxide (NO) response of the penis, ultimately causing priapism. This should incite clinicians for a close follow-up and monitoring of high risk patients who are susceptible to developing priapism. © 2014 Informa Healthcare USA, Inc. All rights reserved.
dc.identifier.doihttps://doi.org/10.3109/03630269.2014.960087
dc.identifier.eid2-s2.0-84907483028
dc.identifier.pmid25271993
dc.identifier.urihttp://hdl.handle.net/10938/30173
dc.language.isoen
dc.publisherInforma Healthcare
dc.relation.ispartofHemoglobin
dc.sourceScopus
dc.subjectHypercoagulability
dc.subjectNitric oxide (no)
dc.subjectPriapism
dc.subjectΒ-thalassemia intermedia (β-ti)
dc.subjectAdrenergic beta-antagonists
dc.subjectAdult
dc.subjectBeta-thalassemia
dc.subjectCombined modality therapy
dc.subjectDrug combinations
dc.subjectHistamine h1 antagonists
dc.subjectHumans
dc.subjectMale
dc.subjectPropranolol
dc.subjectPseudoephedrine
dc.subjectSeverity of illness index
dc.subjectTreatment outcome
dc.subjectTriprolidine
dc.subjectBeta adrenergic receptor blocking agent
dc.subjectDrug combination
dc.subjectHistamine h1 receptor antagonist
dc.subjectPseudoephedrine, triprolidine drug combination
dc.subjectCase report
dc.subjectHuman
dc.subjectMultimodality cancer therapy
dc.subjectPathophysiology
dc.titlePriapism, an emerging complication in β-thalassemia intermedia patients
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2014-5283.pdf
Size:
618.22 KB
Format:
Adobe Portable Document Format